Sonic's Earnings Likely Dented by Pathology Changes -- Market Talk

Dow Jones

2025/07/01

2216 GMT - Sonic Healthcare's revenue is likely to be dented by changes to pathology reimbursements through Australia's Medicare system, Jefferies says. The changes are due to start from FY 2026. They include amendments to urine examinations and Vitamin B12 testing. Analyst David Stanton assesses the impact to be an around A$90 million reduction in annual revenue across the industry. "We estimate that Sonic has circa 46% of the Australian Pathology market and will be able to offset circa 40% of this revenue impost via an increase in out of pockets," Jefferies says. So, it thinks the impact will be a A$24.9 million cut to Sonic's Ebit in FY 2026. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

June 30, 2025 18:16 ET (22:16 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2548006043"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548006043\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2548006043?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-01 06:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548006043","market":"fut","top_or_hot":-1,"title":"Sonic's Earnings Likely Dented by Pathology Changes -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  2216 GMT - <a href=\"https://laohu8.com/S/SHL.AU\">Sonic Healthcare</a>'s revenue is likely to be dented by changes to pathology reimbursements through Australia's Medicare system, Jefferies says. The changes are due to start from FY 2026. They include amendments to urine examinations and Vitamin B12 testing. Analyst David Stanton assesses the impact to be an around A$90 million reduction in annual revenue across the industry. \"We estimate that Sonic has circa 46% of the Australian Pathology market and will be able to offset circa 40% of this revenue impost via an increase in out of pockets,\" Jefferies says. So, it thinks the impact will be a A$24.9 million cut to Sonic's Ebit in FY 2026. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 30, 2025 18:16 ET (22:16 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sonic's Earnings Likely Dented by Pathology Changes -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSonic's Earnings Likely Dented by Pathology Changes -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-01 06:16</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  2216 GMT - <a href=\"https://laohu8.com/S/SHL.AU\">Sonic Healthcare</a>'s revenue is likely to be dented by changes to pathology reimbursements through Australia's Medicare system, Jefferies says. The changes are due to start from FY 2026. They include amendments to urine examinations and Vitamin B12 testing. Analyst David Stanton assesses the impact to be an around A$90 million reduction in annual revenue across the industry. \"We estimate that Sonic has circa 46% of the Australian Pathology market and will be able to offset circa 40% of this revenue impost via an increase in out of pockets,\" Jefferies says. So, it thinks the impact will be a A$24.9 million cut to Sonic's Ebit in FY 2026. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 30, 2025 18:16 ET (22:16 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SHL.AU","symbol_name":"SONIC HEALTHCARE LTD","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2548006043","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548006043","pubTimestamp":1751321760,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2216 GMT - Sonic Healthcare's revenue is likely to be dented by changes to pathology reimbursements through Australia's Medicare system, Jefferies says. The changes are due to start from FY 2026. They include amendments to urine examinations and Vitamin B12 testing. Analyst David Stanton assesses the impact to be an around A$90 million reduction in annual revenue across the industry. \"We estimate that Sonic has circa 46% of the Australian Pathology market and will be able to offset circa 40% of this revenue impost via an increase in out of pockets,\" Jefferies says. So, it thinks the impact will be a A$24.9 million cut to Sonic's Ebit in FY 2026. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"SHL.AU":"SONIC HEALTHCARE LTD"},"translate_title":"Sonic的盈利可能因病理变化而受到影响——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SHL.AU":0.9},"content_text":"2216 GMT - Sonic Healthcare's revenue is likely to be dented by changes to pathology reimbursements through Australia's Medicare system, Jefferies says. The changes are due to start from FY 2026. They include amendments to urine examinations and Vitamin B12 testing. Analyst David Stanton assesses the impact to be an around A$90 million reduction in annual revenue across the industry. \"We estimate that Sonic has circa 46% of the Australian Pathology market and will be able to offset circa 40% of this revenue impost via an increase in out of pockets,\" Jefferies says. So, it thinks the impact will be a A$24.9 million cut to Sonic's Ebit in FY 2026. (david.winning@wsj.com; @dwinningWSJ) \n\n\n  (END) Dow Jones Newswires\n\n\n  June 30, 2025 18:16 ET (22:16 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}